Biocon’s Q4 net profit jumps 250% to Rs 361 crore on exceptional income

Amount of Rs 268 crore, allocated for research earlier, was shown as income after inking pact for rh insulin with Mexico-based firm

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s